Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
High content analysis of 3D chondrogenic pellets derived from primary cells in vitro : research data underlying the article
ID
Voga, Lucija
(
Author
),
ID
Burnik, Tilen
(
Author
),
ID
Kandušer, Maša
(
Author
),
ID
Jeras, Matjaž
(
Author
),
ID
Zupan, Janja
(
Author
),
ID
Trojner-Bregar, Andreja
(
Author
)
DOCX - Data description,
Download
(13,55 KB)
MD5: 771548ECD611AF59564192D229331038
Description: README
ZIP - Research data,
Download
(12,91 KB)
MD5: 4832C9D449797A82F37A5C4B72989A38
Description: Raw data
ZIP - Research data,
Download
(71,08 MB)
MD5: 078A229C7F34C4B58D29AD9A93C7DCE6
Description: Images
Image galllery
Abstract
Primary cells derived from connective tissues contain mesenchymal stem/stromal cell (MSC)–like progenitors with chondrogenic potential relevant for cartilage repair. However, donor and tissue specific variability and the lack of robust, high throughput analytical methods limit their translational use. Objectives: This study aimed to develop and optimize a high content imaging workflow for quantitative evaluation of chondrogenesis in three dimensional (3D) pellets derived from primary cells. Methods: Primary human cells isolated from cartilage were chondrogenically differentiated in vitro. A systematic optimization of immunofluorescence staining parameters was performed, including staining platform, enzymatic matrix digestion, non specific site blocking, membrane permeabilization, and nuclear counterstaining. Type II collagen was detected using an Alexa Fluor 488–conjugated antibody, and pellets were analyzed using high content non-confocal imaging. Fluorescence intensities were adjusted to pellet area to account for size dependent effects. Results: Staining directly in imaging plates enabled streamlined high content analysis. Controlled pepsin mediated matrix digestion markedly enhanced antibody penetration, while excessive digestion compromised pellet integrity. Extended bovine serum albumin blocking improved type II collagen signal intensity and homogeneity. Triton X 100 permeabilization increased detection sensitivity but occasionally induced structural disruption in weakly organized control spheroids. The optimized protocol enabled clear discrimination between chondrogenic pellets and controls, with approximately threefold higher type II collagen signal in chondrogenic samples. Conclusions: This study establishes a high content imaging–based workflow for quantitative assessment of 3D chondrogenesis from primary cells. The approach provides a rapid, scalable platform with direct relevance for in vitro screening, potency testing, and quality control in cartilage oriented advanced therapy development.
Language:
English
Keywords:
primary MSCs
,
3D chondrogenesis
,
pellets
,
high-content analysis
,
type II collagen
,
immunofluorescence
Typology:
2.20 - Complete scientific database of research data
Organization:
FFA - Faculty of Pharmacy
Year:
2026
PID:
20.500.12556/RUL-182207
Data col. methods:
Measurements and tests
Publication date in RUL:
18.05.2026
Views:
406
Downloads:
119
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
primarne MSC
,
3D hondrogeneza
,
peleti
,
avtomatizirana kvantitativna analiza mikroskopskih slik
,
kolagen tipa II
,
imunofluorescenca
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
I0-E011
Name:
EATRIS
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
L3-3176
Name:
Vloga in možna uporaba imunomodulatornih mezenhimskih matičnih celic v zdravljenju bolezni COVID-19
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0420
Name:
Napredna imunološka zdravila in celični pristopi v farmaciji
Funder:
UKC - Univerzitetni klinični center Ljubljana
Name:
Evaluation of the properties of primary cells from various perinatal tissues for use in regenerative medicine
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back